Welcome to LookChem.com Sign In|Join Free

CAS

  • or

2279-15-4

Post Buying Request

2279-15-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2279-15-4 Usage

Description

N-Cbz-D-Tryptophan, also known as Nα-Cbz-D-tryptophan, is an N-Cbz-protected form of D-Tryptophan (T947205). D-Tryptophan is an unnatural isomer of L-Tryptophan (T947210) and is classified as an essential amino acid. It plays a significant role in various biological processes and has potential applications in the pharmaceutical industry due to its unique properties.

Uses

Used in Pharmaceutical Industry:
N-Cbz-D-Tryptophan is used as a building block for the synthesis of various pharmaceutical compounds. Its application is primarily due to its status as an essential amino acid, which can be incorporated into the structure of different drugs to enhance their efficacy or modify their properties.
Used in Synthesis of Oxytocin Antagonists:
N-Cbz-D-Tryptophan is used as a key component in the synthesis of potent Oxytocin antagonists. These antagonists are crucial in the treatment of preterm labor, as they help regulate the hormone levels and prevent premature birth.
Used in Research and Development:
N-Cbz-D-Tryptophan is also utilized in research and development for studying the properties and functions of D-amino acids. Its unique structure allows scientists to explore new avenues in drug design and development, potentially leading to the discovery of novel therapeutic agents.

Check Digit Verification of cas no

The CAS Registry Mumber 2279-15-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,2,7 and 9 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 2279-15:
(6*2)+(5*2)+(4*7)+(3*9)+(2*1)+(1*5)=84
84 % 10 = 4
So 2279-15-4 is a valid CAS Registry Number.
InChI:InChI=1/C19H18N2O4/c22-18(23)17(10-14-11-20-16-9-5-4-8-15(14)16)21-19(24)25-12-13-6-2-1-3-7-13/h1-9,11,17,20H,10,12H2,(H,21,24)(H,22,23)/t17-/m1/s1

2279-15-4 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (C2130)  Nα-Carbobenzoxy-D-tryptophan  >98.0%(HPLC)(T)

  • 2279-15-4

  • 1g

  • 270.00CNY

  • Detail
  • TCI America

  • (C2130)  Nα-Carbobenzoxy-D-tryptophan  >98.0%(HPLC)(T)

  • 2279-15-4

  • 5g

  • 790.00CNY

  • Detail
  • Alfa Aesar

  • (L08769)  N(alpha)-Benzyloxycarbonyl-D-tryptophan, 98+%   

  • 2279-15-4

  • 250mg

  • 170.0CNY

  • Detail
  • Alfa Aesar

  • (L08769)  N(alpha)-Benzyloxycarbonyl-D-tryptophan, 98+%   

  • 2279-15-4

  • 1g

  • 487.0CNY

  • Detail

2279-15-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name (2R)-3-(1H-indol-3-yl)-2-(phenylmethoxycarbonylamino)propanoic acid

1.2 Other means of identification

Product number -
Other names Cbz-D-Trp-OH

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:2279-15-4 SDS

2279-15-4Relevant articles and documents

Beyond the Diketopiperazine Family with Alternatively Bridged Brevianamide F Analogues

Wauters,Goossens,Delbeke,Muylaert,Roman,Van Hecke,Van Speybroeck,Stevens

, p. 8046 - 8054 (2015/09/02)

A method for the preparation of 3,5-bridged piperazin-2-ones from a tryptophan-proline-based diketopiperazine is described using diphosgene to induce the ring closure. Density functional theory calculations were conducted to study the mechanism of this C-C bond formation. Several derivatives of the thus obtained α-chloroamine were synthesized by substitution of the chlorine atom using a range of O-, N-, S-, and C-nucleophiles. This novel class of brevianamide F analogues possess interesting breast cancer resistance protein inhibitory activity.

A concise preparation of the non-proteinogenic amino acid l-kynurenine

Kleijn, Laurens H.J.,Müskens, Frederike M.,Oppedijk, Sabine F.,De Bruin, Gerjan,Martin, Nathaniel I.

supporting information, p. 6430 - 6432 (2013/01/15)

A concise and practical preparation of the non-proteinogenic amino acid l-kynurenine is reported. The synthetic approach is scalable and provides ready access to this valuable amino acid in either l- or d-stereochemistry starting from l- or d-tryptophan, respectively. In the optimized procedure, two discreet oxidation steps are applied sequentially to convert the tryptophan indole ring into the keto-aniline moiety contained within the kynurenine side chain.

Cyclodextrin-mediated deacylation of amino acid esters with marked stereoselectivity.

Goto, Koichi,Nakashima, Kentaro,Tanoue, Osamu,Nukushina, Satoshi,Toudo, Isao,Imamura, Chikara,Ihara, Yasuji,Matsumoto, Yoko,Ueoka, Ryuichi

, p. 1283 - 1285 (2007/10/03)

With respect to the hydrolysis (deacylation) of Z-D(L)-amino acid esters (N-(benzyloxycarbonyl)-D(L)-amino acid p-nitrophenyl esters) mediated by alpha-, beta- and gamma-cyclodextrins (CyDs), a remarkably high enantioselectivity (L/D=9.0) was observed for the deacylation of Ala substrate with gamma-CyD. The kinetic results on the basis of the Michaelis-Menten principle indicate that the enantioselectivity should be mainly originated in the deacylation process of substrates following the formation of gamma-CyD-substrate (1 : 1) complexes. The computer modeling (molecular mechanics) studies on the inclusion complexes are also described.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 2279-15-4